|
|
|
|
| LEADER |
01723nam a2200313 u 4500 |
| 001 |
EB001865468 |
| 003 |
EBX01000000000000001029548 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
190504 r ||| eng |
| 100 |
1 |
|
|a Sutton, Desirée
|
| 245 |
0 |
0 |
|a Off-label use of intravenous immunoglobulin for neurological conditions
|h Elektronische Ressource
|b a review of clinical effectiveness
|c authors, Desirée Sutton, Sarah Visintini
|
| 246 |
3 |
1 |
|a Off-label use of IVIG for neurology
|
| 250 |
|
|
|a Version: 1.0
|
| 260 |
|
|
|a Ottawa
|b CADTH
|c 2018, March 14, 2018
|
| 300 |
|
|
|a 1 PDF file (70 pages)
|b illustration
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Off-Label Use
|
| 653 |
|
|
|a Treatment Outcome
|
| 653 |
|
|
|a Immunoglobulins, Intravenous / therapeutic use
|
| 653 |
|
|
|a Nervous System Diseases / drug therapy
|
| 700 |
1 |
|
|a Visintini, Sarah
|e [author]
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a CADTH rapid response report: summary with critical appraisal
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK531883
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a The purpose of this Rapid Response Report is to collect, critically appraise and evaluate the current evidence on the clinical effectiveness off-label use of intravenous immunoglobulin for the treatment of neurological or neuromuscular conditions. This report is a full-text review of studies originally identified in the CADTH Rapid Response Summary of Abstracts report: Off-Label Use of Intravenous Immunoglobulin for Neurological Conditions
|